Figure S1
Schematic of GLOW and GLOW-EX study design. D, day; GLOW, Gelesis Loss Of Weight study; GLOW-EX, Gelesis Loss Of Weight 24-week extension study; V, visit; W, week; PO, taken by mouth. Figure S1 . Study design.
a Patients who did not enroll into GLOW-EX were followed through week 28 (for 28 days of follow-up). b On day of enrollment into GLOW-EX (baseline for GLOW-EX), Gelesis100 was dispensed to patients, and they were instructed to start administration of Gelesis100 before lunch and dinner on the following day. c To ensure that the weight of hydrated Gelesis100 (which could be up to 1 kg) did not mask weight loss, the treatment assessment of body weight was performed and weight-related parameters were recorded approximately 60 hours after the last administration of Gelesis100 (day 171 for GLOW and day 339 for GLOW-EX). 
